Björklund Pharma is an early-stage biopharmaceutical company with product candidates within the following therapeutic areas:

• Psychiatry
• Neurology
• Pain
• Sleep
• Dermatology
• Ophthalmology
• Cardiology
• Gastrointestinal
• Immunology
• Infectious diseases
• Bone metabolism
• Toxicology
• Pulmonology/respiratory
• Renal/hepatic
• Nutraceuticals

Most of the company’s product candidates are in an early preclinical stage. During the preclinical phase, various tests and experiments will be conducted to determine drugs’ safety, effectiveness, and how they are metabolized in the body. This information will be used to design and plan clinical trials to test the drugs on human subjects.